.
Schema-Root.org logo

 

  cross-referenced news and research resources about

 Merck

images:  google   yahoo

Sat. October 11, 2008

+
Lyon, 10th October 2008 - RotaTeq®, the pentavalent rotavirus vaccine from Sanofi Pasteur MSD and Merck & Co. Inc., that helps prevent rotavirus ...
Datamonitor expects JnJ/Tibotec and Merck to be the fastest growing companies over the next 10 years. While Tibotec only entered the field with the launch ...
Merck also added that it has committed to provide additional safety and efficacy data from Africa and Asia, and is currently conducting clinical trials in ...
In 2005, Hi-Tech Pharmacal (HITK) became the first company to file a paragraph IV certification relating to Merck's (MRK) glaucoma drugs Trusopt and Cosopt. ...

It was only in March of last year that a national experts' committee recommended that teenage girls get vaccinated with Merck's Gardasil, which protects ...
But even here, drug companies seem to be in a no-win situation -- witness Merck and Schering-Plough getting flack for releasing some safety-related data ...
By Bloomberg News Mylan Inc., the biggest US maker of generic drugs, is "well capitalized" and able to manage debt from last year's purchase of Merck KGaA's ...
... partnership between Vanderbilt Kennedy Center and the Vanderbilt Department of Psychiatry. It is funded by a three-year grant from the John Merck Fund.
He said data released earlier in the year by Gardasil's manufacturer, Merck & Co., show that only about 1% of Latina teens were receiving the vaccine, ...
The figures represent the government's first substantial study of vaccination rates for Gardasil, Merck's heavily advertised, three-shot series that targets ...
New evidence emerging from the Merck lawsuits over the painkiller Vioxx shows that the company repeatedly lied to both the FDA and respected medical ...
(NaturalNews) children who take Merck's combination vaccine ProQuad suffer from convulsions twice as frequently as children who are given two separate ...
By Shannon Pettypiece Oct. 9 (Bloomberg) -- Merck & Co.'s cervical cancer vaccine Gardasil was given to a quarter of teenage girls last year after a $100 ...
Even though Merck, the drug's manufacturer, recently added depression and suicidal thoughts to the list of less common side effects, their parents say ...
EMD Chemicals is a United States subsidiary of Merck KGaA in Darmstadt, Germany. KGaA's materials. After successfully meeting initial development milestones ...
Results of a new study find that a drug from Merck called Proscar, which is used to control a man's enlarged prostate, does not increase the risk of hip ...
Merck has announced that researchers are to conduct a clinical trial of its HIV treatment raltegravir. The medicine will be assessed as a once-daily dose in ...
By Mass High Tech Staff Nanotechnology firm Nano-Terra Inc. and German drug maker Merck KGaA have upgraded their product development partnership to a ...
EMD Chemicals Inc., the US division of Merck KGaA of Germany, said today it is extending its existing alliance with Nano-Terra Inc., a Cambridge start-up ...
After Lilly's announcement, Merck & Co. said it would also begin disclosing payments to doctors, starting next year. Those are welcome steps, presuming the ...
In April, for example, a group of academic doctors questioned the validity of drug industry research after finding that Merck had hired ghostwriters to ...
Chitsulo was accompanied by representatives from Merck KGaA, which makes praziquantel, the most effective medicine against schistosomiasis. ...
The second-largest was the $58 million May agreement reached with Merck & Co. (nyse:MRK) over Vioxx, a settlement that netted Ohio $2.84 million. ...
In connection with the financing, Alan Sachs , MD, Ph.D., Vice President of RNA Therapeutics for Merck Research Laboratories, was elected to the Odyssey ...
It is the largest settlement paid by a drug company in a state consumer protection case, topping the $58 million that Merck paid to settle similar ...
Now, due to a lawsuit over the injuries caused by Merck's painkiller Vioxx, Merck has been forced to unseal documents over its initial research on Vioxx ...
Lilly Chief Executive John Lechleiter told analysts he looked forward to working with Bristol-Myers, which markets Erbitux in the US and Canada , and Merck ...
The challenge was that the pricey system Merck Research Labs originally invested in proved to be labor-intensive and convoluted, needing its own cadre of ...
If you're going to look out more than a year or two, you'd have a tough time convincing anyone that Merck, Pfizer, J&J and Bristol Myers are all going out ...
By Dianna Cooper Merck & Co. has decided to bring to an end the development the experimental obesity drug taranabant on account of its many adverse events, ...
Traiger said he expects he'll be able to vaccinate his patients once Merck, the drug's manufacturer, catches up with the orders. Traiger is waiting for his ...
Since the FDA began its investigation, Merck, the drug's manufacturer, says it has been "informing doctors and patients of this new information in several ...
In the immediate aftermath of the vote, shares of Pfizer Inc., Merck & Co., Bristol-Myers Squibb Co., Abbott Laboratories and Eli Lilly all lost some ground ...
Merck licensed the right to market Erbitux outside the US and Canada from Imclone Systems Incorporated of New York in 1998. In Japan, ImClone Systems ...
By Brian Orelli After lackluster results in a phase 3 trial, Merck (nyse: MRK) has decided that it's just not very high on its anti-obesity compound anymore ...
Discovered and developed by Merck, aprepitant is the first in a new class of medicines (neurokinin-1 (NK1) receptor antagonist), indicated in combination ...
... over a cisplatinum-based chemotherapy and across all histological subtypes," said Dr Wolfgang Wein, Executive Vice President, Oncology, Merck Serono. ...
NEW YORK (Associated Press) - Merck & Co. said Thursday it will end a late-stage development program on its potential obesity drug taranabant and abandon ...
Bristol-Myers Squibb (nyse: BMY) sells it in the US and Canada and pays ImClone a 39% royalty rate, and Merck KGaA has the rights elsewhere with a 9.5% ...
By Peter Loftus Merck & Co. (MRK) took a gamble with an experimental anti-obesity drug, and it didn't pay off. The drug giant Thursday said it halted ...

URL of RSS 2.0 feed    Subscribe in NewsGator Online    Subscribe to this Schema-Root.org "Merck" feed via Bloglines


 


schema-root.org

     merck

pharmaceutical manufacturers:
     astrazeneca
     eli lilly
     glaxosmithkline
     merck
     novartis
     pfizer
     research
     takeda
     upjohn

page tools:

short url:
http://schema-root.org/p/2553

Send link to a friend

Google cache of page


schemata ©2008 John Tinker